2Geradts J, Kratzkle RA, Niehans GA, et al. Immunohistochemical detection of the cyclin-dependent kinase inhibito 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4Ain archival human solid tumors: Correlation with retinoblastoma protein. Cancer Res, 1995, 55: 6606～6011.
3Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclinD/CDK4. Nature, 1993, 336: 704～707.
4Kamb A, Gruis NA, Weauer Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types.Science, 1994, 264: 436～440.
5Nobori T, Miura K, Wu DJ, et al. Delections of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 1994, 368: 753～756.
6Tsuda H, Yamamoto K, Inoue T, et al. The role of p16-cyclind/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma. Br J Cancer, 2000, 82 (3): 675～682.
7Ito K, Sasano H, Yoshida Y, et al. Immunohistochemical study of cyclin D and E and cyclin dependent kinase (cdk) 2 and 4 in human endometrial carcinoma. Anticancer Res, 1998, 18(3A); 1661～1674.
8Nikaido T, Li SF, Shiozawa T, et al. Coabnormal expression of cyclinD1 and p53 protein in human uterine endometrial carcinoma.Cancer, 1996, 78 (6): 1248～1253.
9Darnell JE Jr. STATs and gene regulation. Science, 1997, 277:1630-1635.
10Bromberg J, Darnell JE Jr. The role of STATs in transcriptional control and their impact on cellular function. Oncogene, 2000, 19: 2468-2473.
